- IBDEI20H ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32103,0)
- ;;=Z30.46^^126^1646^19
- ;;^UTILITY(U,$J,358.3,32103,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32103,1,3,0)
- ;;=3^Surveillance Implantable Subdermal (Nexplanon),F/U
- ;;^UTILITY(U,$J,358.3,32103,1,4,0)
- ;;=4^Z30.46
- ;;^UTILITY(U,$J,358.3,32103,2)
- ;;=^5140424
- ;;^UTILITY(U,$J,358.3,32104,0)
- ;;=Z30.45^^126^1646^20
- ;;^UTILITY(U,$J,358.3,32104,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32104,1,3,0)
- ;;=3^Surveillance Transdermal Patch Hormonal (Ortho Evra),F/U
- ;;^UTILITY(U,$J,358.3,32104,1,4,0)
- ;;=4^Z30.45
- ;;^UTILITY(U,$J,358.3,32104,2)
- ;;=^5140423
- ;;^UTILITY(U,$J,358.3,32105,0)
- ;;=Z30.44^^126^1646^21
- ;;^UTILITY(U,$J,358.3,32105,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32105,1,3,0)
- ;;=3^Surveillance Vaginal Ring Hormonal (NuvaRing),F/U
- ;;^UTILITY(U,$J,358.3,32105,1,4,0)
- ;;=4^Z30.44
- ;;^UTILITY(U,$J,358.3,32105,2)
- ;;=^5140422
- ;;^UTILITY(U,$J,358.3,32106,0)
- ;;=Z30.016^^126^1646^22
- ;;^UTILITY(U,$J,358.3,32106,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32106,1,3,0)
- ;;=3^Transdermal Patch Hormonal Device (Ortho Evra),Initial
- ;;^UTILITY(U,$J,358.3,32106,1,4,0)
- ;;=4^Z30.016
- ;;^UTILITY(U,$J,358.3,32106,2)
- ;;=^5140420
- ;;^UTILITY(U,$J,358.3,32107,0)
- ;;=Z30.015^^126^1646^24
- ;;^UTILITY(U,$J,358.3,32107,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32107,1,3,0)
- ;;=3^Vaginal Ring Hormonal (NuvaRing),Initial
- ;;^UTILITY(U,$J,358.3,32107,1,4,0)
- ;;=4^Z30.015
- ;;^UTILITY(U,$J,358.3,32107,2)
- ;;=^5140419
- ;;^UTILITY(U,$J,358.3,32108,0)
- ;;=Z90.710^^126^1647^1
- ;;^UTILITY(U,$J,358.3,32108,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32108,1,3,0)
- ;;=3^Acquired Absence of Cervix & Uterus
- ;;^UTILITY(U,$J,358.3,32108,1,4,0)
- ;;=4^Z90.710
- ;;^UTILITY(U,$J,358.3,32108,2)
- ;;=^5063591
- ;;^UTILITY(U,$J,358.3,32109,0)
- ;;=Z90.712^^126^1647^2
- ;;^UTILITY(U,$J,358.3,32109,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32109,1,3,0)
- ;;=3^Acquired Absence of Cervix w/ Remaining Uterus
- ;;^UTILITY(U,$J,358.3,32109,1,4,0)
- ;;=4^Z90.712
- ;;^UTILITY(U,$J,358.3,32109,2)
- ;;=^5063593
- ;;^UTILITY(U,$J,358.3,32110,0)
- ;;=R87.619^^126^1647^3
- ;;^UTILITY(U,$J,358.3,32110,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32110,1,3,0)
- ;;=3^Atypical Gland Cells,Undet Signif (AGCUS) Pap
- ;;^UTILITY(U,$J,358.3,32110,1,4,0)
- ;;=4^R87.619
- ;;^UTILITY(U,$J,358.3,32110,2)
- ;;=^5019676
- ;;^UTILITY(U,$J,358.3,32111,0)
- ;;=R87.611^^126^1647^4
- ;;^UTILITY(U,$J,358.3,32111,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32111,1,3,0)
- ;;=3^Atypical Squam Cell,Not Excl Hi Grd Intrepith Lesn Cyto Smr Crvx
- ;;^UTILITY(U,$J,358.3,32111,1,4,0)
- ;;=4^R87.611
- ;;^UTILITY(U,$J,358.3,32111,2)
- ;;=^5019669
- ;;^UTILITY(U,$J,358.3,32112,0)
- ;;=D06.9^^126^1647^5
- ;;^UTILITY(U,$J,358.3,32112,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32112,1,3,0)
- ;;=3^CA in Situ,Cervix
- ;;^UTILITY(U,$J,358.3,32112,1,4,0)
- ;;=4^D06.9
- ;;^UTILITY(U,$J,358.3,32112,2)
- ;;=^5001941
- ;;^UTILITY(U,$J,358.3,32113,0)
- ;;=D06.1^^126^1647^7
- ;;^UTILITY(U,$J,358.3,32113,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32113,1,3,0)
- ;;=3^CA in Situ,Exocervix
- ;;^UTILITY(U,$J,358.3,32113,1,4,0)
- ;;=4^D06.1
- ;;^UTILITY(U,$J,358.3,32113,2)
- ;;=^5001939
- ;;^UTILITY(U,$J,358.3,32114,0)
- ;;=D06.0^^126^1647^6
- ;;^UTILITY(U,$J,358.3,32114,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32114,1,3,0)
- ;;=3^CA in Situ,Endocervix
- ;;^UTILITY(U,$J,358.3,32114,1,4,0)
- ;;=4^D06.0
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI20H 3765 printed Feb 18, 2025@23:45:43 Page 2
- IBDEI20H ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32103,0)
- +2 ;;=Z30.46^^126^1646^19
- +3 ;;^UTILITY(U,$J,358.3,32103,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,32103,1,3,0)
- +6 ;;=3^Surveillance Implantable Subdermal (Nexplanon),F/U
- +7 ;;^UTILITY(U,$J,358.3,32103,1,4,0)
- +8 ;;=4^Z30.46
- +9 ;;^UTILITY(U,$J,358.3,32103,2)
- +10 ;;=^5140424
- +11 ;;^UTILITY(U,$J,358.3,32104,0)
- +12 ;;=Z30.45^^126^1646^20
- +13 ;;^UTILITY(U,$J,358.3,32104,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,32104,1,3,0)
- +16 ;;=3^Surveillance Transdermal Patch Hormonal (Ortho Evra),F/U
- +17 ;;^UTILITY(U,$J,358.3,32104,1,4,0)
- +18 ;;=4^Z30.45
- +19 ;;^UTILITY(U,$J,358.3,32104,2)
- +20 ;;=^5140423
- +21 ;;^UTILITY(U,$J,358.3,32105,0)
- +22 ;;=Z30.44^^126^1646^21
- +23 ;;^UTILITY(U,$J,358.3,32105,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,32105,1,3,0)
- +26 ;;=3^Surveillance Vaginal Ring Hormonal (NuvaRing),F/U
- +27 ;;^UTILITY(U,$J,358.3,32105,1,4,0)
- +28 ;;=4^Z30.44
- +29 ;;^UTILITY(U,$J,358.3,32105,2)
- +30 ;;=^5140422
- +31 ;;^UTILITY(U,$J,358.3,32106,0)
- +32 ;;=Z30.016^^126^1646^22
- +33 ;;^UTILITY(U,$J,358.3,32106,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,32106,1,3,0)
- +36 ;;=3^Transdermal Patch Hormonal Device (Ortho Evra),Initial
- +37 ;;^UTILITY(U,$J,358.3,32106,1,4,0)
- +38 ;;=4^Z30.016
- +39 ;;^UTILITY(U,$J,358.3,32106,2)
- +40 ;;=^5140420
- +41 ;;^UTILITY(U,$J,358.3,32107,0)
- +42 ;;=Z30.015^^126^1646^24
- +43 ;;^UTILITY(U,$J,358.3,32107,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,32107,1,3,0)
- +46 ;;=3^Vaginal Ring Hormonal (NuvaRing),Initial
- +47 ;;^UTILITY(U,$J,358.3,32107,1,4,0)
- +48 ;;=4^Z30.015
- +49 ;;^UTILITY(U,$J,358.3,32107,2)
- +50 ;;=^5140419
- +51 ;;^UTILITY(U,$J,358.3,32108,0)
- +52 ;;=Z90.710^^126^1647^1
- +53 ;;^UTILITY(U,$J,358.3,32108,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,32108,1,3,0)
- +56 ;;=3^Acquired Absence of Cervix & Uterus
- +57 ;;^UTILITY(U,$J,358.3,32108,1,4,0)
- +58 ;;=4^Z90.710
- +59 ;;^UTILITY(U,$J,358.3,32108,2)
- +60 ;;=^5063591
- +61 ;;^UTILITY(U,$J,358.3,32109,0)
- +62 ;;=Z90.712^^126^1647^2
- +63 ;;^UTILITY(U,$J,358.3,32109,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,32109,1,3,0)
- +66 ;;=3^Acquired Absence of Cervix w/ Remaining Uterus
- +67 ;;^UTILITY(U,$J,358.3,32109,1,4,0)
- +68 ;;=4^Z90.712
- +69 ;;^UTILITY(U,$J,358.3,32109,2)
- +70 ;;=^5063593
- +71 ;;^UTILITY(U,$J,358.3,32110,0)
- +72 ;;=R87.619^^126^1647^3
- +73 ;;^UTILITY(U,$J,358.3,32110,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,32110,1,3,0)
- +76 ;;=3^Atypical Gland Cells,Undet Signif (AGCUS) Pap
- +77 ;;^UTILITY(U,$J,358.3,32110,1,4,0)
- +78 ;;=4^R87.619
- +79 ;;^UTILITY(U,$J,358.3,32110,2)
- +80 ;;=^5019676
- +81 ;;^UTILITY(U,$J,358.3,32111,0)
- +82 ;;=R87.611^^126^1647^4
- +83 ;;^UTILITY(U,$J,358.3,32111,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,32111,1,3,0)
- +86 ;;=3^Atypical Squam Cell,Not Excl Hi Grd Intrepith Lesn Cyto Smr Crvx
- +87 ;;^UTILITY(U,$J,358.3,32111,1,4,0)
- +88 ;;=4^R87.611
- +89 ;;^UTILITY(U,$J,358.3,32111,2)
- +90 ;;=^5019669
- +91 ;;^UTILITY(U,$J,358.3,32112,0)
- +92 ;;=D06.9^^126^1647^5
- +93 ;;^UTILITY(U,$J,358.3,32112,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,32112,1,3,0)
- +96 ;;=3^CA in Situ,Cervix
- +97 ;;^UTILITY(U,$J,358.3,32112,1,4,0)
- +98 ;;=4^D06.9
- +99 ;;^UTILITY(U,$J,358.3,32112,2)
- +100 ;;=^5001941
- +101 ;;^UTILITY(U,$J,358.3,32113,0)
- +102 ;;=D06.1^^126^1647^7
- +103 ;;^UTILITY(U,$J,358.3,32113,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,32113,1,3,0)
- +106 ;;=3^CA in Situ,Exocervix
- +107 ;;^UTILITY(U,$J,358.3,32113,1,4,0)
- +108 ;;=4^D06.1
- +109 ;;^UTILITY(U,$J,358.3,32113,2)
- +110 ;;=^5001939
- +111 ;;^UTILITY(U,$J,358.3,32114,0)
- +112 ;;=D06.0^^126^1647^6
- +113 ;;^UTILITY(U,$J,358.3,32114,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,32114,1,3,0)
- +116 ;;=3^CA in Situ,Endocervix
- +117 ;;^UTILITY(U,$J,358.3,32114,1,4,0)
- +118 ;;=4^D06.0